Who owns Jazz Pharmaceuticals (JAZZ)? Superinvestor holders

5 superinvestors of the 157 tracked here hold Jazz Pharmaceuticals (JAZZ) in their latest 13F filing, with $888.2M between them. Tweedy, Browne team gives it the most weight: 1.12% of the reported portfolio. In their latest reported quarter, Tweedy, Browne team, Josef Lakonishok, Jim Simons (1938–2024) and Ken Griffin and 1 more reduced.

Steve Cohen sold out of it in their latest quarter.

Hold it now
5
of 157 tracked
Combined value
$888.2M
Bought / sold
0 / 6
last quarter

Key facts

Superinvestors holding it
5 of 157
Biggest holder
Josef Lakonishok, $494.5M
Largest weight
Tweedy, Browne team, 1.12%of their portfolio
Combined value
$888.2M
Bought last quarter
0
Sold last quarter
6

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding JAZZ, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Tweedy, Browne teamTweedy, Browne Company1.12%$13.7M59.28K▼ Reduced 1.5%−872Q3 2026
2Josef LakonishokLSV Asset Management0.91%$494.5M2.14M▼ Reduced 6.1%−139.24KQ3 2026
3Jim Simons (1938–2024)Renaissance Technologies0.15%$112M483.57K▼ Reduced 14%−78.53KQ3 2026
4Ken GriffinCitadel Advisors0.14%$242.6M1.01M▼ Reduced 20%−252.77KQ2 2026
5Howard GleicherAristotle Capital Management0.06%$25.4M109.78K▼ Reduced 1.7%−1.91KQ3 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of JAZZ by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269242.79M$645.6M04
Q2 202615754.02M$967.7M06
Q1 202615776.65M$1.3B43
Q4 202515755.24M$891.5M23
Q3 202515744.2M$553.5M22
Q2 202515722.72M$288.6M21
Q1 202515654.41M$547.8M32
Q4 202415643.92M$482.9M22

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of JAZZ held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Josef Lakonishok2.14M2.28M2.39M2.46M2.51M2.55M2.47M2.53M
Jim Simons (1938–2024)483.57K562.07K819.37K836.77K924.87K—1.04M1M
Howard Gleicher109.78K111.7K130.55K158.84K158.06K165.57K158.87K195.94K
Tweedy, Browne team59.28K60.15K60.21K—————
Ken Griffin·1.01M1.26M—————
Israel Englander·—1.26M1.2M————
Brandon Haley·—733.91K589.74K605.11K—492.03K—
Ray Dalio (founder)·—————250.95K192.04K

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own JAZZ?

In their latest 13F filings: Tweedy, Browne team (1.12% of the portfolio, $13.7M), Josef Lakonishok (0.91% of the portfolio, $494.5M), Jim Simons (1938–2024) (0.15% of the portfolio, $112M), Ken Griffin (0.14% of the portfolio, $242.6M), Howard Gleicher (0.06% of the portfolio, $25.4M).

Who sold JAZZ last quarter?

Reduced: Tweedy, Browne team (1.5% fewer shares), Josef Lakonishok (6.1% fewer shares), Jim Simons (1938–2024) (14% fewer shares), Ken Griffin (20% fewer shares), Howard Gleicher (1.7% fewer shares). Sold out entirely: Steve Cohen (was $67.8M).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Jazz Pharmaceuticals (JAZZ)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/JAZZ/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to JAZZ by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.